Source: VC News Daily

T. Rowe Price: Arbor Biotechnologies Announces $73.9 Million Series C

BOSTON, MA, Arbor Biotechnologies announced the closing of a $73.9 million Series C financing.

Read full article »
Annual Revenue
$5.0-10B
Employees
5.0-10K
Robert W. Sharps's photo - President & CEO of T. Rowe Price

President & CEO

Robert W. Sharps

CEO Approval Rating

60/100

Read more